Canadian Neuroscience Seminars – Post-doc series – June 5: Vincent Hervé & Dotun Adeyinka

Speaker #1

Dotun Adeyinka, Acadia University

Investigating the Neurobiology and Neurophysiology of Psilocybin Using Drosophila melanogaster as a Model System.

I have a PhD in Neurobiology from the University of Fribourg, Switzerland, where my work focused on the interplay between neural stem cell state transitions and the cell cycle in the brain, using Drosophila melanogaster as a model organism. I also worked briefly as a researcher at King’s College London & Imperial College London, UK, on stem cell regeneration and cell fate. I am presently a postdoctoral researcher in the Faraone group, department of chemistry, Acadia University- where I am investigating how psilocybin influences important neurotransmitters like serotonin- which modulates stress, decision-making, and behaviour, using Drosophila melanogaster as a model. My research combines behavioural assays, genetic tools, and in vivo imaging to understand the neural basis of mental health conditions. My research endeavours centres on neurodevelopment, neuropharmacology and behavioural studies. Twitter/ X handle: @dotun_adey

Speaker #2

Vincent Herve, Université de Montréal

The Direct Impact Of Amyloid-beta Oligomers On Neuronal Activity And Neurotransmitter Releases On In Vivo Analysis.

Vincent is a biochemist with a master’s degree in biochemistry, biotechnology, and structural biology from the University Paul Sabatier in Toulouse, France. During his studies, he contributed to research on the oxidation of amyloid beta peptides and investigated mechanisms of plant adaptation to changing environments. He moved to Canada to pursue a Ph.D. at the Institut National de la Recherche Scientifique (INRS) in Laval, where he focused on Apolipoprotein D, exploring its role in cognitive decline and its ability to cross the blood-brain barrier. In 2022, after crossing the Rivière des Prairies, Vincent began a postdoctoral fellowship at the Université de Montréal in the laboratory of Dr. Jonathan Brouillette. His current research investigates the impact of amyloid beta on neuronal hyperactivity and neurotransmitter release in the rat hippocampus, aiming to shed light on the early mechanisms of Alzheimer’s disease—particularly the silent accumulation of amyloid beta peptides, which can begin 15 to 20 years before clinical symptoms emerge. Alongside his research, Vincent is deeply committed to science communication and actively contributes to various outreach and educational initiatives within the lab.

Linkedin :https://www.linkedin.com/in/vincent-herve/
Twitter : https://x.com/Vince_herve
Bluesky : https://bsky.app/profile/vincent-herve.bsky.social

Webinar link 

https://zoom.us/webinar/register/3217374850132/WN_rOTKD5qZRECA2JBDof-Y6w